Catastrophic brain relapse in seronegative NMO after a single dose of natalizumab

Joanna Kitley1, Nikos Evangelou2, Wilhelm Küker3

  • 1Nuffield Department of Clinical Neurosciences, Oxford University Hospitals NHS Trust, University of Oxford, Oxford, UK.